Clinical Trial Update: Daily Vitamin D for Sickle-cell Respiratory Complications [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating daily vitamin D for sickle cell–related respiratory complications has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Chest Syndrome
• Respiratory Tract Infections
• Sickle Cell Disease
• Vitamin Deficiency

Drugs mentioned

• Vitamin D3 (Cholecalciferol) (Cholecalciferol)

Snippet

Sponsor: Columbia University | Conditions: Sickle Cell Disease, Anemia, Sickle Cell | Phase 2 | Status: COMPLETED | Results posted: 2025-09-24